002262 恩华药业
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资149,3393.77%143,91197,31872,54678,384
投资性房地产48,688-2.24%49,80452,03650,51652,629
固定资产1,225,0810.22%1,222,3581,237,8231,141,1561,145,313
在建工程335,924-8.20%365,938309,381293,76092,071
无形资产308,88924.01%249,078232,090190,466111,104
商誉0--0000
其他非流动资产730,9230.24%729,190451,806325,191351,249
2,798,8441.40%2,760,2792,380,4542,073,6341,830,750

流动资产
货币资金1,221,997-15.70%1,449,6061,416,3892,158,9461,532,214
应收账款1,756,58419.34%1,471,8671,490,2281,034,736820,839
存货858,19913.40%756,784661,394628,637716,340
其他流动资产2,899,4224.12%2,784,6972,491,5411,432,2411,581,010
6,736,2024.23%6,462,9526,059,5525,254,5614,650,403

流动负债
短期借款40,00033.33%30,00015,00055,00030,000
应付票据274,781-11.89%311,846280,52560,91529,558
应付帐款285,68316.56%245,103287,828216,284226,181
其他流动负债482,823-4.45%505,291482,888481,829508,204
1,083,286-0.82%1,092,2401,066,241814,028793,943
流动资产净值5,652,9165.25%5,370,7134,993,3114,440,5343,856,460
资产总额减流动负债8,451,7603.95%8,130,9927,373,7656,514,1685,687,210

非流动负债
长期借款2300.00%230230230230
应付债券0--0000
其他非流动负债89,054-13.43%102,866100,019103,830103,253
89,284-13.40%103,096100,249104,060103,483

总权益
    实收股本1,015,7870.00%1,015,7871,016,1771,007,5881,007,588
    储备项目7,375,7164.75%7,041,3486,284,1455,426,5534,613,926
股东权益8,391,5034.15%8,057,1357,300,3226,434,1415,621,515
非控股权益(29,026)-0.73%(29,239)(26,806)(24,034)(37,788)